Edition:
United Kingdom

Pernix Therapeutics Holdings Inc (PTX.OQ)

PTX.OQ on NASDAQ Stock Exchange Global Market

2.36USD
19 Apr 2018
Change (% chg)

-- (--)
Prev Close
$2.36
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
19,736
52-wk High
$7.15
52-wk Low
$2.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 41.54 -2.797
Sep '17 40.47 0.385
Jun '17 34.32 -2.158
Mar '17 29.74 -2.941
FY 2016 Dec '16 30.17 -8.908
Sep '16 41.47 -2.990
Jun '16 36.75 -4.669
Mar '16 32.47 -4.243
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.95 32.74
P/E High - Last 5 Yrs. -- 40.70 45.72
P/E Low - Last 5 Yrs. -- 23.63 24.22
Beta 1.69 0.89 0.88
Price to Sales (TTM) 0.26 3.94 5.71
Price to Book (MRQ) -- 4.80 5.37
Price to Tangible Book (MRQ) -- 5.61 6.95
Price to Cash Flow (TTM) -- 22.91 23.32
% Owned Institutions 21.30 1.21 2.17

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.51
Dividend 5 Year Growth Rate -- 4.47 5.32
Payout Ratio(TTM) -- 45.35 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -6.61 3.69 9.21
Sales (TTM) vs TTM 1 Yr. Ago -17.36 4.83 5.69
Sales - 5 Yr. Growth Rate 18.37 10.08 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago 53.78 16.36 19.36
EPS (TTM) vs TTM 1 Yr. Ago 29.25 -- --
EPS - 5 Yr. Growth Rate -- 9.87 10.76
Capital Spending - 5 Yr. Growth Rate 41.15 15.52 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.67 2.12 2.19
Current Ratio (MRQ) 0.75 2.90 2.98
LT Debt to Equity (MRQ) -- 9.88 12.18
Total Debt to Equity (MRQ) -- 13.86 16.45
Interest Coverage (TTM) -9.29 35.89 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 70.21 54.81 54.44
Gross Margin - 5 Yr. Avg. 64.57 52.15 52.20
EBITD Margin (TTM) 4.02 -- --
EBITD - 5 Yr. Avg -0.57 18.57 10.96
Operating Margin (TTM) -93.55 14.36 4.73
Operating Margin - 5 Yr. Avg. -56.18 14.52 6.40
Pre-Tax Margin (TTM) -120.18 14.82 5.57
Pre-Tax Margin - 5 Yr. Avg. -69.72 14.90 6.81
Net Profit Margin (TTM) -120.56 11.08 1.87
Net Profit Margin - 5 Yr. Avg. -65.04 11.20 3.09
Effective Tax Rate (TTM) -- 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. -- 23.42 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 733,508 938,079,949 846,830,978
Net Income/Employee (TTM) -884,286 110,368,367 99,616,195
Receivable Turnover (TTM) 2.90 5.63 5.78
Inventory Turnover (TTM) 4.45 2.59 3.35
Asset Turnover (TTM) 0.42 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -50.40 11.40 10.95
Return on Assets - 5 Yr. Avg. -23.23 12.91 12.31
Return on Investment (TTM) -74.47 14.84 14.38
Return on Investment - 5 Yr. Avg. -31.36 16.88 16.10
Return on Equity (TTM) -- 16.34 16.07
Return on Equity - 5 Yr. Avg. -138.91 17.98 17.39
  1 Year 3 Year 5 Year
Sales % -19.90 18.40 18.37
EPS (TTM) % 22.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Pernix Therapeutics Holdings Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 19.01%
# of Holders: 38
Total Shares Held: 2,257,439
3 Mo. Net Change: 3,000
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 0
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.